Gene · 4017
Papers2,536
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 2,536
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multi-omics analysis reveals focal adhesion characteristic associated tumor immune microenvironment in colon adenocarcinoma. | Front Genet | 2023 | 36950136 | PubTator, text mining | PubMed |
| Intraperitoneal transfer of microRNA-29b-containing small extracellular vesicles can suppress peritoneal metastases of gastric cancer. | Cancer Sci | 2023 | 36939028 | PubTator, text mining | PubMed |
| Identification of the novel therapeutic targets and biomarkers associated of prostate cancer with cancer-associated fibroblasts (CAFs). | Front Oncol | 2023 | 36937411 | PubTator, text mining | PubMed |
| Inhibition of lysyl oxidases synergizes with 5-azacytidine to restore erythropoiesis in myelodysplastic and myeloid malignancies. | Nat Commun | 2023 | 36932114 | PubTator, text mining | PubMed |
| Heat shock proteins and cancer: The FoxM1 connection. | Biochem Pharmacol | 2023 | 36931349 | PubTator, text mining | PubMed |
| Genetic Role in Recurrence of Idiopathic CTEV: A Systematic Review. | Orthop Res Rev | 2023 | 36926520 | PubTator, text mining | PubMed |
| Antioxidant and anti-inflammatory agents in chronic liver diseases: Molecular mechanisms and therapy. | World J Hepatol | 2023 | 36926234 | PubTator, text mining | PubMed |
| Are genes the missing link to detect and prognosticate RA-ILD? | Rheumatol Adv Pract | 2023 | 36923263 | PubTator, text mining | PubMed |
| Correction: Lysyl Oxidase-like Protein LOXL2 Promotes Lung Metastasis of Breast Cancer. | Cancer Res | 2023 | 36919424 | PubTator, text mining | PubMed |
| Immune determinants of the pre-metastatic niche. | Cancer Cell | 2023 | 36917952 | PubTator, text mining | PubMed |
| Screening of potential pain genes in pancreatic ductal adenocarcinoma (PDAC) based on bioinformatics methods. | J Gastrointest Oncol | 2023 | 36915423 | PubTator, text mining | PubMed |
| Single-cell and spatial dissection of precancerous lesions underlying the initiation process of oral squamous cell carcinoma. | Cell Discov | 2023 | 36914617 | PubTator, text mining | PubMed |
| Passing the post: roles of posttranslational modifications in the form and function of extracellular matrix. | Am J Physiol Cell Physiol | 2023 | 36912485 | PubTator, text mining | PubMed |
| LOXL1 and LOXL4 are novel target genes of the Zn2+-bound form of ZEB1 and play a crucial role in the acceleration of invasive events in triple-negative breast cancer cells. | Front Oncol | 2023 | 36910659 | PubTator, text mining | PubMed |
| New insights into fibrotic signaling in renal cell carcinoma. | Front Cell Dev Biol | 2023 | 36910160 | PubTator, text mining | PubMed |
| Crystal structures of di-μ-chlorido-bis-({(E)-5-(ethyl-amino)-4-methyl-2-[(pyridin-2-yl)diazen-yl]phen-o-lato}copper(II)) and chlorido-bis-(1,10-phen-anthroline)copper(II) chloride tetra-hydrate. | Acta Crystallogr E Crystallogr Commun | 2023 | 36909989 | PubTator, text mining | PubMed |
| Emerging Therapeutic Targets for Portal Hypertension. | Curr Hepatol Rep | 2023 | 36908849 | PubTator, text mining | PubMed |
| Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments. | Mol Cancer | 2023 | 36906534 | PubTator, text mining | PubMed |
| Autoimmune Hepatitis and Fibrosis. | J Clin Med | 2023 | 36902767 | PubTator, text mining | PubMed |
| The Role of Proteomics and Phosphoproteomics in the Discovery of Therapeutic Targets and Biomarkers in Acquired EGFR-TKI-Resistant Non-Small Cell Lung Cancer. | Int J Mol Sci | 2023 | 36902280 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4017/papers?page=23